Oxford Biomedica plc
$5.00
24H
Market Cap
Volume
Supply
Price Chart
About Oxford Biomedica plc - OXB.L
Oxford Biomedica plc is a biopharmaceutical company specializing in the development and manufacture of gene and cell therapies, using their proprietary lentiviral vector delivery platform. They collaborate with a range of partners in the pharmaceutical industry to support the development and commercialization of these novel treatments.
What are Oxford Biomedica plc's core values and mission statement?
Oxford Biomedica's mission centers on delivering life-changing gene therapies to patients, and they uphold core values that include innovation, integrity, collaboration, and excellence, put into practice through their cutting-edge research and commitment to developing transformative treatments.
Who founded Oxford Biomedica plc and when?
Oxford Biomedica plc was founded by Alan Kingsman and Susan Kingsman in 1995.
Who leads Oxford Biomedica plc?
As of my last update, the CEO of Oxford Biomedica plc was John Dawson.
Where is Oxford Biomedica plc located, and what is its base country?
Oxford Biomedica plc is located in Oxford, England, and its base country is the United Kingdom.
On which exchanges is Oxford Biomedica plc traded?
Oxford Biomedica plc is traded on the London Stock Exchange (LSE) under the symbol OXB.
Historical data
Oxford Biomedica plc (OXB) Price Live Data
The live price of Oxford Biomedica plc (OXB) is $5.00, with a trading volume of 22,102 in the last 24 hours. Wrapstocks updates the OXB price in real-time. Oxford Biomedica plc is up 0.24% in the last 24 hours. The company has a live market cap of $5,349,910.07 and a supply of 1,070,770 OXB stocks.
Oxford Biomedica plc (OXB) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 8 hours and 47 minutes.
